Polianta Ltd Buys New Position in DuPont de Nemours, Inc. $DD

Polianta Ltd bought a new position in DuPont de Nemours, Inc. (NYSE:DDFree Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 37,400 shares of the basic materials company’s stock, valued at approximately $1,503,000.

Several other institutional investors have also recently added to or reduced their stakes in DD. Salomon & Ludwin LLC grew its stake in shares of DuPont de Nemours by 186.5% in the 3rd quarter. Salomon & Ludwin LLC now owns 318 shares of the basic materials company’s stock valued at $25,000 after buying an additional 207 shares during the period. Palisade Asset Management LLC acquired a new position in DuPont de Nemours during the 3rd quarter worth approximately $26,000. Financial Life Planners acquired a new position in DuPont de Nemours during the 3rd quarter worth approximately $27,000. Imprint Wealth LLC bought a new position in DuPont de Nemours in the third quarter worth approximately $27,000. Finally, Measured Wealth Private Client Group LLC bought a new position in DuPont de Nemours in the third quarter worth approximately $30,000. 73.96% of the stock is owned by institutional investors and hedge funds.

DuPont de Nemours Stock Performance

Shares of DuPont de Nemours stock opened at $44.17 on Tuesday. DuPont de Nemours, Inc. has a 52 week low of $22.50 and a 52 week high of $52.66. The company has a quick ratio of 1.91, a current ratio of 2.42 and a debt-to-equity ratio of 0.22. The business has a 50 day moving average price of $46.69 and a 200-day moving average price of $40.78. The company has a market cap of $18.06 billion, a PE ratio of -23.75, a price-to-earnings-growth ratio of 1.13 and a beta of 1.09.

DuPont de Nemours (NYSE:DDGet Free Report) last announced its earnings results on Tuesday, February 10th. The basic materials company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.03. The company had revenue of ($1,871.00) million for the quarter, compared to analysts’ expectations of $1.69 billion. DuPont de Nemours had a positive return on equity of 7.37% and a negative net margin of 7.03%.DuPont de Nemours’s quarterly revenue was up .2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.13 earnings per share. DuPont de Nemours has set its FY 2026 guidance at 2.250-2.300 EPS and its Q1 2026 guidance at 0.480-0.480 EPS. Equities analysts anticipate that DuPont de Nemours, Inc. will post 4.38 earnings per share for the current fiscal year.

DuPont de Nemours Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 16th. Stockholders of record on Monday, March 2nd were paid a $0.20 dividend. The ex-dividend date was Monday, March 2nd. This represents a $0.80 annualized dividend and a dividend yield of 1.8%. DuPont de Nemours’s dividend payout ratio is presently -43.01%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on DD shares. KeyCorp boosted their price objective on DuPont de Nemours from $51.00 to $57.00 and gave the company an “overweight” rating in a report on Wednesday, February 11th. Argus cut their target price on DuPont de Nemours from $86.00 to $52.00 and set a “buy” rating on the stock in a report on Thursday, February 5th. Wall Street Zen upgraded shares of DuPont de Nemours to a “hold” rating in a research note on Saturday, January 10th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of DuPont de Nemours from $46.00 to $58.00 and gave the stock a “buy” rating in a report on Wednesday, February 18th. Finally, Wolfe Research raised their price objective on shares of DuPont de Nemours from $49.00 to $54.00 and gave the company an “outperform” rating in a research note on Wednesday, February 11th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $51.86.

Read Our Latest Report on DD

About DuPont de Nemours

(Free Report)

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.

Featured Stories

Institutional Ownership by Quarter for DuPont de Nemours (NYSE:DD)

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.